Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole.
Anouk M E JansenKim SnijdelaarRon J KeizerIsabel SprietErwin DreesenRoger J M BrüggemannRob Ter HeinePublished in: Clinical pharmacokinetics (2024)
We validated an MIPD strategy for posaconazole for its fit-for-purpose. Thereby, this study is an important first step towards MIPD-supported posaconazole dosage optimization with the goal to improve antifungal treatment in clinical practice.